RVL Pharmaceuticals plc Intangible Assets, Net (Excluding Goodwill)
RVL Pharmaceuticals plc had Intangible Assets, Net (Excluding Goodwill) of $13.90 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2023-08-14
- 2023-03-31: Intangible Assets, Net (Excluding Goodwill) $13.90M.
- 2022-12-31: Intangible Assets, Net (Excluding Goodwill) $13.90M.
- 2022-09-30: Intangible Assets, Net (Excluding Goodwill) $27.21M.
- 2022-06-30: Intangible Assets, Net (Excluding Goodwill) $27.21M.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2023-03-31 | $13.90M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $13.90M 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $27.21M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $27.21M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $27.21M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $27.21M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $27.21M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $27.21M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $63.12M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $35.09M 10-K · filed 2022-03-30 | $65.76M 10-K · filed 2021-03-30 |
| 2020-09-30 | $117.90M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $141.64M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $149.62M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $64.00M 10-Q · filed 2021-11-15 | $153.99M 10-K · filed 2020-03-19 |
| 2019-09-30 | $189.32M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $330.89M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $473.52M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $83.70M 8-K · filed 2021-09-08 | $490.39M 10-K · filed 2019-03-28 |
| 2018-09-30 | $521.24M 10-Q · filed 2018-11-08 | |
| 2017-12-31 | $585.39M 10-K · filed 2020-03-19 | $585.39M 10-Q · filed 2018-11-08 |
| 2016-12-31 | $701.29M 8-K · filed 2019-12-20 |